Professional Documents
Culture Documents
TEST 1:
The overall outsourcing expenditure has been steadily increasing year upon year for
the pharma industry, with a 6% increase in the number of companies spending more
than $50 million per year or more on outsourcing their services. Analysts have
predicted that the Global Healthcare Business Process Outsourcing market will accelerate at
a CAGR of 9.8% from 2020-2025.
Factors that are responsible for the growth of the market include rapid increase in
clinical process outsourcing (CPO), implementation of PPACA ( Patient
Protection and Affordable Care Act) compelled healthcare player to move toward
outsourcing, and fewer errors in several non-critical functions, like finance and
accounting, customer care services, etc.
Europe
Asia Pacific
Latin America
2.Enhances the profitability and reduction in cost: It is one of the most important
healthcare benefits for outsourcing because it helps to save nearly 30 to 60 per cent
of the costs those can be incurred with the help of local resources. The inbound
services in healthcare outsourcing helps in bringing some efficient resources and
the infrastructure just at some low cost which increases the profit margins in the
clinics and hospitals.
4. Don’t need to scratch your head for changing regulations: When you
outsource it to others, you don’t need to worry about the ever-changing rules, which
can be a quite daunting task for you. But the vendors those you have outsourced to,
have trained the personnel in order to cope with new guidelines, laws and rules.
7. Helps to avoid data entry errors: A small error in the patient’s medical record
can be dangerous for the healthcare business. However, outsourcing companies
stick to rules and ensure that a patient’s record remains secure and confidential.
They also help in eliminating medical billing errors.
8. Get more time to focus on the patients: Outsourcing services can help
healthcare businesses to focus on more on their patients by reducing their
administrative burden. This will eventually increase the quality of care.
Pfizer has undertaken a similar strategy in the US, having positioned many of its
research and development facilities close to major bioscience hubs, such as San
Francisco and La Jolla in California and Cambridge, Massachusetts.
Please fill the latest available capacity of the mentioned cement plant:
TEST 3:
PPT attached in the mail